Fiducial markers are described as the object set in the viewing field of an imaging system, which appears in the image produced, and which can be used as a point of reference. Fiducial markers are inserted for defining and targeting the lesions, which are resided in the soft tissues of the chest, pelvis, abdomen, head, and neck. The placement of fiducial marker is an image-guided method that is performed by interventional radiologists in preparation for several types of radiation therapy, including stereotactic body radiotherapy (SBRT), proton therapy, and stereotactic radiosurgery (SRS).
MARKET DYNAMICS
The fiducial markers market is fueled by increasing investments, funds, and grants by public-private organizations for cancer research, rising cancer burden globally in the forecasted period. Additionally, technological advancements in the market and the rising acceptance of radiotherapy procedures in developing countries will boost the market growth to significant extent over the forecast period. However, a dearth of skilled and experienced oncologists in developing countries and the slow adoption of advanced technologies may hinder the growth of the market in the forecasted period.
MARKET SCOPE
The "Global Fiducial Markers Market Analysis to 2028" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of fiducial markers market with detailed market segmentation by product, modality, application, end-user and geography. The global fiducial markers market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading fiducial markers market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global fiducial markers market is segmented on product, modality, application, and end-user. Based on product, the global fiducial markers market is segmented into metal-based markers, polymer-based markers and other fiducial markers. Based on modality, the global fiducial markers market is segmented into radiotherapy, ultrasound, MRI, and CT. Based on application, the global fiducial markers market is segmented into lung cancer, breast cancer, prostrate cancer, gastric cancer, and others. Based on end user, the global fiducial markers market is segmented into hospitals and outpatient facilities, independent radiotherapy centers, and cancer research centers.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global fiducial markers market based on various segments. It also provides market size and forecast estimates from year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The fiducial markers market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting fiducial markers market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Fiducial markers market in these regions.
MARKET PLAYERS
The reports cover key developments in the fiducial markers market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from fiducial markers market are anticipated to lucrative growth opportunities in the future with the rising demand for fiducial markers market in the global market. Below mentioned is the list of few companies engaged in the fiducial markers market.
The report also includes the profiles of key fiducial markers market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- CIVCO Radiotherapy
- IZI Medical Products
- Boston Scientific Corporation
- Naslund Medical AB
- Medtronic
- QlRad Inc
- Carbon Medical Technologies
- Eckert and Ziegler
- Innovative Oncology Solutions
- JJ-Medtech
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.